Ofloxacin / Ornidazole Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200mg+ 500mg
Reference Brands: Various Indian Brand
Category:
Anthelmintic
Ofloxacin+Ornidazole is used in the treatment of bacterial & parasitic infections. It is used to treat gastrointestinal infections such as acute diarrhea or dysentery, gynecological infections, lung infections and urinary infections.
Ofloxacin / Ornidazole Tablets is available in Tablets
and strengths such as 200mg+ 500mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ofloxacin / Ornidazole Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ofloxacin / Ornidazole Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ofloxacin 200 mg and Ornidazole 500 mg combination tablet is a potent antibiotic and antiprotozoal formulation used to treat a variety of mixed infections. It is especially effective in managing gastrointestinal infections such as diarrhea and dysentery, as well as certain pelvic and gynecological infections caused by bacterial and protozoal pathogens. The combination works through a dual mechanism: ofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase and topoisomerase IV, preventing bacterial replication, while ornidazole, a nitroimidazole derivative, disrupts the DNA of protozoal organisms, effectively eliminating parasites.
This combination tablet is typically prescribed for short-course therapy to ensure rapid relief of symptoms such as abdominal pain, fever, and abnormal discharge while preventing the progression of infection. It is well-suited for infections where both bacterial and protozoal organisms are suspected. Common side effects include nausea, headache, dizziness, and a metallic taste, but these are generally mild and transient. Proper medical supervision is essential to ensure safe use, prevent drug interactions, and reduce the risk of antimicrobial resistance. The tablet provides a convenient, single-dose approach for the effective management of mixed infections.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing